GIVEAWAY: Gaming peripherals upgrade thanks to Corsair worth $280

Here's how we could speed up a coronavirus COVID-19 vaccine being made

This new idea could be what speeds up vaccine development for the coronavirus COVID-19.

Published Tue, May 12 2020 8:33 AM CDT   |   Updated Mon, Oct 19 2020 8:19 PM CDT

Thousands of people have put their hands up for this process that could speed up the development of a COVID-19 vaccine.

Here's how we could speed up a coronavirus COVID-19 vaccine being made 09 |

Vaccine development takes quite a long time, as all potential vaccines must go through several levels of regulation before they are rolled out to the public. This process is extended depending on how complicated the disease the vaccine is trying to give immunity against, but what if there was a way to speed up the process?

Originally, vaccine development comes in three phases; Phase 1 is when a vaccine candidate is given to animals and/or a very small group of people. Phase 2 is the clinical study and the vaccine is given to people who have the same kind of characteristics the vaccine is intended for. Phase 3 is when the vaccine is given to thousands of people and tested for efficacy and safety.

Phase 3 takes the longest amount of time, and because this process can take quite some time a March paper from National Center for Biotechnology Information says we can speed up this process by a few months if we start infecting volunteers with vaccine candidates in a controlled environment.

"Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines. By replacing conventional Phase 3 testing of vaccine candidates, such trials may subtract many months from the licensure process, making efficacious vaccines available more quickly."

This idea of course doesn't come without its own risks:

"Obviously, challenging volunteers with this live virus risks inducing severe disease and possibly even death. However, we argue that such studies, by accelerating vaccine evaluation, could reduce the global burden of coronavirus-related mortality and morbidity. Volunteers in such studies could autonomously authorize the risks to themselves, and their net risk could be acceptable if participants comprise healthy young adults, who are at relatively low risk of serious disease following natural infection, they have a high baseline risk of natural infection, and during the trial they receive frequent monitoring and, following any infection, the best available care."

You are probably thinking that there would be minimal people to put their hand up for a such a trial? Well, according to 1DaySooner, more than 16,000 people have already raised their hands for a human experimental trial if one was to happen.

Buy at Amazon

Geekirumi! handmade crochet amigurumi coronavirus stress ball

TodayYesterday7 days ago30 days ago
* Prices last scanned on 10/21/2020 at 12:40 pm CDT - prices may not be accurate, click links above for the latest price. We may earn an affiliate commission.

Jak's love for technology, and, more specifically, PC gaming, began at 10 years old. It was the day his dad showed him how to play Age of Empires on an old Compaq PC. Ever since that day, Jak fell in love with games and the progression of the technology industry in all its forms. Instead of typical FPS, Jak holds a very special spot in his heart for RTS games.

Related Tags

Newsletter Subscription
Latest News
View More News
Latest Reviews
View More Reviews
Latest Articles
View More Articles